Categories

gb ONCO CLL gb ONCO CLL

gb ONCO CLL

Detection method: reverse transcription + real-time PCR

This in vitro diagnostic kit is intended for prognosis assessment in CLL patients by analysis of cDNA (reverse transcribed RNA) samples of human B lymphocytes obtained from peripheral blood. The kit is based on reverse transcription together with quantitative real-time polymerase chain reaction (qRT-PCR) using fluorescently labelled probes.

Clinical implications of the CE IVD kit

Chronic lymphocytic leukemia (CLL) occurs mostly in elderly people (median age 65 years) and is the most common leukemia in Europe and North America where CLL comprises of about 30 % of leukemic diseases of adults. The frequency of CLL is approximately two-times higher in men than in women. IGHV mutational status analysis helps to better predict disease progression and patient survival.

Somatic hypermutation of IGHV is the physiological process that leads to an increase in antibody diversity. In patients with mutated IGHV, better prognosis with a slower progression of disease and a longer patient´s survival can be observed. In those with unmutated IGHV a worse clinical course and prognosis can be expected.The kit contains all components necessary for analysis of gene expression. Two of six genes are housekeeping genes (B2M, HPRT1) and three of them are target genes (LPL, ZAP70 and COBLL1). The remaining gene CD3D serves as contamination marker (sample contamination by T lymphocytes).

Parameters of the real-time PCR diagnostic kit

  • ready-to-use assays
  • RNA input 500–1000 ng
  • reverse transcription reagents included
  • negative and positive controls included
  • FAM channel detection
Cat. No. Product No. of tests Price
3240-010 gb ONCO CLL 10
Add to Quote
Add to Quote

1 CE IVD real-time PCR kit contains reagents to provide 30 PCR reactions (20 μl volume of each reaction) – test for 10 patients.

Shiping on dry ice from € 110 (EU)
For other destinations see indicative list.

    About product

    General Terms and Conditions

    Validated for:

    ABI 7300 (ABI)

    ABI 7900HT (ABI)

    AriaMx (Agilent Technologies)

    CFX96/96Touch (Bio-Rad)

    iCycler iQ5 (Bio-Rad)

    MIC (BMS)

    RG 3000 (Corbett Research)

    RG 6000/Q (Corbett Research/Qiagen)

    Select further cyclers

    Useful links
    Recommended products
    Dual-labeled hydrolysis probes

    Dual-labeled hydrolysis probes Dual-labeled hydrolysis probes

    The technology of dual-labeled hydrolysis probes (also called TaqMan® real-time PCR probes) exploits the 5 ́-3 ́ exonuclease activity of Taq DNA polymerase to cleave the probe. TaqMan real-time PCR probes are labeled with a fluorescent dye (reporter) at the 5´ end and with a quencher at the 3´ end.

    More
    Recommended articles